Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Study Overview
=================
Brief Summary
-----------------
A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Detailed Description
-----------------
A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Official Title
-----------------
Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With Minority Populations

Conditions
-----------------
Vaccine Preventable Disease

Intervention / Treatment
-----------------
* Other: Educational, culturally appropriate COVID-19 messages


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Self-identification within a CLs social network Age 18 or greater Functional internet access. Exclusion Criteria: Does not self-identify within a CLs social network Is under the age of 18 Does not have functional internet access.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 101 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention Arm - Receives COVID-19 Vaccine messages<br>Group to receive COVID-19 Vaccine messages during the first two weeks of the study. | Other: Educational, culturally appropriate COVID-19 messages<br>* Educational, culturally appropriate COVID-19 messages will be developed and shared by RHCP.<br>|
| Experimental: Delayed Intervention Arm<br>Group to receive COVID-19 Vaccine messages during the last two weeks of the study. | Other: Educational, culturally appropriate COVID-19 messages<br>* Educational, culturally appropriate COVID-19 messages will be developed and shared by RHCP.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| COVID-19 attitudes | Related to perceived susceptibility and preventive measures will be assessed through 3 survey instruments, based on 7-point Likert scale. | 4 weeks | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
hesitancy